---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264467102.md"
description: "Lunai Bioworks shares are trading higher after the company announced the publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal \"Vaccines\"."
datetime: "2025-11-05T15:05:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264467102.md)
  - [en](https://longbridge.com/en/news/264467102.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264467102.md)
---

# 

Lunai Bioworks shares are trading higher after the company announced the publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines".

### Related Stocks

- [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md)
- [RENB.US](https://longbridge.com/en/quote/RENB.US.md)

## Related News & Research

- [Lunai Bioworks announces availability of CEO shareholder letter](https://longbridge.com/en/news/290058803.md)
- [09:30 ETLanai Launches AI @ Work Operating System to Help Enterprises Close the AI Accountability Gap](https://longbridge.com/en/news/283010611.md)
- [12:16 ETLunakai Highlights Public Health and Stress Awareness in April](https://longbridge.com/en/news/281400535.md)
- [09:00 ETDelonix Bioworks Announces Initiation of Phase 1 First-in-Human Clinical Trial of a Next-Generation MenB OMV Vaccine DX-104](https://longbridge.com/en/news/281025352.md)